Distinct IL-1α-responsive enhancers promote acute and coordinated changes in chromatin topology in a hierarchical manner.


Journal

The EMBO journal
ISSN: 1460-2075
Titre abrégé: EMBO J
Pays: England
ID NLM: 8208664

Informations de publication

Date de publication:
02 01 2020
Historique:
received: 11 01 2019
revised: 27 09 2019
accepted: 01 10 2019
pubmed: 9 11 2019
medline: 14 7 2020
entrez: 9 11 2019
Statut: ppublish

Résumé

How cytokine-driven changes in chromatin topology are converted into gene regulatory circuits during inflammation still remains unclear. Here, we show that interleukin (IL)-1α induces acute and widespread changes in chromatin accessibility via the TAK1 kinase and NF-κB at regions that are highly enriched for inflammatory disease-relevant SNPs. Two enhancers in the extended chemokine locus on human chromosome 4 regulate the IL-1α-inducible IL8 and CXCL1-3 genes. Both enhancers engage in dynamic spatial interactions with gene promoters in an IL-1α/TAK1-inducible manner. Microdeletions of p65-binding sites in either of the two enhancers impair NF-κB recruitment, suppress activation and biallelic transcription of the IL8/CXCL2 genes, and reshuffle higher-order chromatin interactions as judged by i4C interactome profiles. Notably, these findings support a dominant role of the IL8 "master" enhancer in the regulation of sustained IL-1α signaling, as well as for IL-8 and IL-6 secretion. CRISPR-guided transactivation of the IL8 locus or cross-TAD regulation by TNFα-responsive enhancers in a different model locus supports the existence of complex enhancer hierarchies in response to cytokine stimulation that prime and orchestrate proinflammatory chromatin responses downstream of NF-κB.

Identifiants

pubmed: 31701553
doi: 10.15252/embj.2019101533
pmc: PMC6939198
doi:

Substances chimiques

Chemokines 0
Chromatin 0
IL1A protein, human 0
Inflammation Mediators 0
Interleukin-1alpha 0
NF-kappa B 0
Tumor Necrosis Factor-alpha 0
MAP Kinase Kinase Kinases EC 2.7.11.25
MAP kinase kinase kinase 7 EC 2.7.11.25

Banques de données

GEO
['GSE64224', 'GSE52470', 'GSE134436']
SRA
['PRJNA552438']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e101533

Subventions

Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 162103480
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 284237345
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 183582903
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 268555672
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 197785619
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 162103480
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 183582903
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 197785619
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 285697699
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 290613333
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 24676099
Pays : International
Organisme : Deutsche Forschungsgemeinschaſt (DFG)
ID : 390649896
Pays : International
Organisme : Deutsche Krebshilfe
ID : 111447
Pays : International
Organisme : Max-Planck Society
Pays : International
Organisme : Excellence Cluster Cardio-Pulmonary System and Cardio-Pulmonary Institute (EXC 147: Kardiopulmonales System)
ID : 24676099
Pays : International
Organisme : Cardio-Pulmonary Institute (CPI)
ID : 390649896
Pays : International
Organisme : DZL/UGMLC Program
Pays : International
Organisme : Center for Molecular Medicine Cologne (ZMMK)
Pays : International

Informations de copyright

© 2019 The Authors. Published under the terms of the CC BY 4.0 license.

Références

Mol Cell. 2017 Dec 21;68(6):1067-1082.e12
pubmed: 29272704
J Biol Chem. 2005 Mar 11;280(10):9706-18
pubmed: 15615716
J Vis Exp. 2018 Apr 2;(134):
pubmed: 29658938
Trends Biochem Sci. 2017 Aug;42(8):612-624
pubmed: 28566214
Methods Mol Biol. 2016;1418:335-51
pubmed: 27008022
Mol Cell. 2014 Jan 23;53(2):193-208
pubmed: 24389100
Nat Genet. 2019 Jan;51(1):138-150
pubmed: 30531872
J Biol Chem. 1994 Dec 16;269(50):31836-44
pubmed: 7527398
Mediators Inflamm. 2017;2017:7848591
pubmed: 28490839
Hum Mol Genet. 2017 Feb 15;26(4):742-752
pubmed: 28007912
Trends Cell Biol. 2018 Aug;28(8):608-630
pubmed: 29759817
Epigenomics. 2017 Sep;9(9):1219-1231
pubmed: 28799793
Nat Rev Drug Discov. 2009 Jun;8(6):480-99
pubmed: 19483709
Cell Rep. 2015 Feb 10;10(5):726-739
pubmed: 25660023
Nat Genet. 2008 Jul;40(7):897-903
pubmed: 18552846
J Exp Med. 1955 Jul 1;102(1):37-48
pubmed: 14392239
Nature. 2015 Jan 29;517(7536):583-8
pubmed: 25494202
Nat Protoc. 2013 Mar;8(3):509-24
pubmed: 23411633
Annu Rev Immunol. 2014;32:489-511
pubmed: 24555473
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Mol Cell Biol. 2012 Jul;32(14):2738-47
pubmed: 22586273
Theranostics. 2017 Apr 7;7(6):1543-1588
pubmed: 28529637
Nat Commun. 2018 Jul 25;9(1):2905
pubmed: 30046115
Immunol Cell Biol. 2007 Jun;85(4):315-22
pubmed: 17438562
Genome Res. 2016 Nov;26(11):1478-1489
pubmed: 27633323
Cell. 2018 Apr 5;173(2):386-399.e12
pubmed: 29625054
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Rev Genet. 2013 Jun;14(6):390-403
pubmed: 23657480
Curr Opin Cell Biol. 2013 Dec;25(6):759-64
pubmed: 23906851
Mol Biol Cell. 2009 Apr;20(7):2070-82
pubmed: 19211845
Mol Cell. 2016 Apr 21;62(2):237-247
pubmed: 27067601
Cold Spring Harb Perspect Biol. 2014 Sep 11;6(11):a016261
pubmed: 25213094
PLoS Biol. 2010 Jul 13;8(7):e1000419
pubmed: 20644712
Cytokine. 1997 Jul;9(7):471-9
pubmed: 9237809
Nat Commun. 2018 Mar 5;9(1):943
pubmed: 29507293
Proc Soc Exp Biol Med. 1955 Jul;89(3):362-4
pubmed: 13254761
BMC Genomics. 2014 Apr 15;15:284
pubmed: 24735413
Cell. 2017 Jan 12;168(1-2):37-57
pubmed: 28086098
Cell. 2008 Jul 11;134(1):85-96
pubmed: 18614013
Annu Rev Cell Dev Biol. 2017 Oct 6;33:265-289
pubmed: 28783961
Oncogene. 2018 Jun;37(23):3070-3087
pubmed: 29535421
Wiley Interdiscip Rev Syst Biol Med. 2018 Jan;10(1):
pubmed: 28544514
J Cell Biol. 2019 Jan 7;218(1):12-26
pubmed: 30442643
Annu Rev Immunol. 2010;28:321-42
pubmed: 20307211
Nat Immunol. 2011 Jul 19;12(8):695-708
pubmed: 21772278
Nature. 2012 Sep 6;489(7414):75-82
pubmed: 22955617
J Biol Chem. 2005 Feb 25;280(8):7010-21
pubmed: 15591054
Nat Commun. 2017 Nov 29;8(1):1849
pubmed: 29185442
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Science. 2018 Sep 28;361(6409):1341-1345
pubmed: 30262496
Genome Biol. 2014 Dec 03;15(12):536
pubmed: 25608606
Mol Cell. 2017 Sep 21;67(6):1037-1048.e6
pubmed: 28890333
Chem Rev. 2015 Mar 25;115(6):2274-95
pubmed: 25424540
Curr Opin Immunol. 2017 Feb;44:34-42
pubmed: 27951434
Cytokine Growth Factor Rev. 2016 Oct;31:61-71
pubmed: 27578214
Biochem J. 1991 Aug 1;277 ( Pt 3):635-42
pubmed: 1872799
Nat Commun. 2018 Apr 25;9(1):1661
pubmed: 29695774
J Cell Biol. 2019 Jan 7;218(1):27-38
pubmed: 30181316
Immunity. 2010 Mar 26;32(3):317-28
pubmed: 20206554
Cell. 2016 Nov 17;167(5):1170-1187
pubmed: 27863239
Sci Signal. 2010 Jan 19;3(105):cm2
pubmed: 20086236
Nat Rev Immunol. 2014 Jan;14(1):51-9
pubmed: 24336099
Mol Cell. 2013 Mar 7;49(5):773-82
pubmed: 23473598
Methods Mol Biol. 2013;946:27-38
pubmed: 23179824
Nucleic Acids Res. 2014 Apr;42(8):e68
pubmed: 24561615
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
J Vis Exp. 2013 Aug 15;(78):null
pubmed: 23978815
Trends Cell Biol. 2018 Jul;28(7):509-511
pubmed: 29778529
Nat Genet. 2018 Aug;50(8):1151-1160
pubmed: 29988121
Epigenomics. 2018 Apr 1;10(4):483-498
pubmed: 29583027
Biochem J. 2003 Aug 15;374(Pt 1):1-20
pubmed: 12773095
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Trends Pharmacol Sci. 2012 Oct;33(10):522-30
pubmed: 22795313
Nat Med. 2018 Sep;24(9):1469-1480
pubmed: 30038216
Mol Syst Biol. 2016 Dec 9;12(12):891
pubmed: 27940490
Cancer Res. 2017 Jun 1;77(11):2784-2788
pubmed: 28455420
EMBO J. 2012 Nov 28;31(23):4404-14
pubmed: 23103767
Nat Rev Immunol. 2017 Oct;17(10):595-607
pubmed: 28580958
J Cell Biol. 2011 Aug 22;194(4):581-96
pubmed: 21859862
Cell. 1994 Sep 23;78(6):1039-49
pubmed: 7923354

Auteurs

Sinah-Sophia Weiterer (SS)

Rudolf Buchheim Institute of Pharmacology, Justus Liebig University Giessen, Giessen, Germany.

Johanna Meier-Soelch (J)

Rudolf Buchheim Institute of Pharmacology, Justus Liebig University Giessen, Giessen, Germany.

Theodore Georgomanolis (T)

Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.

Athanasia Mizi (A)

Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
Department of Pathology, University Medical Center Göttingen, Göttingen, Germany.

Anna Beyerlein (A)

Rudolf Buchheim Institute of Pharmacology, Justus Liebig University Giessen, Giessen, Germany.

Hendrik Weiser (H)

Rudolf Buchheim Institute of Pharmacology, Justus Liebig University Giessen, Giessen, Germany.

Lilija Brant (L)

Department of Pathology, University Medical Center Göttingen, Göttingen, Germany.

Christin Mayr-Buro (C)

Rudolf Buchheim Institute of Pharmacology, Justus Liebig University Giessen, Giessen, Germany.

Liane Jurida (L)

Rudolf Buchheim Institute of Pharmacology, Justus Liebig University Giessen, Giessen, Germany.

Knut Beuerlein (K)

Rudolf Buchheim Institute of Pharmacology, Justus Liebig University Giessen, Giessen, Germany.

Helmut Müller (H)

Rudolf Buchheim Institute of Pharmacology, Justus Liebig University Giessen, Giessen, Germany.

Axel Weber (A)

Rudolf Buchheim Institute of Pharmacology, Justus Liebig University Giessen, Giessen, Germany.

Ulas Tenekeci (U)

Rudolf Buchheim Institute of Pharmacology, Justus Liebig University Giessen, Giessen, Germany.

Oliver Dittrich-Breiholz (O)

Research Core Unit Genomics, Institute of Physiological Chemistry, Medical School Hannover, Hannover, Germany.

Marek Bartkuhn (M)

Institute for Genetics, Justus Liebig University Giessen, Giessen, Germany.

Andrea Nist (A)

Genomics Core Facility and Institute of Molecular Oncology, Philipps University Marburg, Marburg, Germany.

Thorsten Stiewe (T)

Genomics Core Facility and Institute of Molecular Oncology, Philipps University Marburg, Marburg, Germany.
Member of the German Center for Lung Research (DZL), Giessen, Germany.

Wilfred Fj van IJcken (WF)

Center for Biomics, Erasmus Medical Center, Rotterdam, The Netherlands.

Tabea Riedlinger (T)

Institute of Biochemistry, Justus Liebig University Giessen, Giessen, Germany.

M Lienhard Schmitz (ML)

Member of the German Center for Lung Research (DZL), Giessen, Germany.
Institute of Biochemistry, Justus Liebig University Giessen, Giessen, Germany.

Argyris Papantonis (A)

Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
Department of Pathology, University Medical Center Göttingen, Göttingen, Germany.

Michael Kracht (M)

Rudolf Buchheim Institute of Pharmacology, Justus Liebig University Giessen, Giessen, Germany.
Member of the German Center for Lung Research (DZL), Giessen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH